Vivacious Pharmatex Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 11-07-2024
- Paid Up Capital ₹ 1.02 Cr
as on 11-07-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.80 Cr
as on 11-07-2024
- Satisfied Charges ₹ 6.25 Cr
as on 11-07-2024
- Revenue 389.84%
(FY 2022)
- Profit 104.91%
(FY 2022)
- Ebitda 50.29%
(FY 2022)
- Net Worth 23.67%
(FY 2022)
- Total Assets -6.68%
(FY 2022)
About Vivacious Pharmatex
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.02 Cr.
The company currently has active open charges totaling ₹3.80 Cr. The company has closed loans amounting to ₹6.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Priya Shrivastav, Rupam Shrivastav, and Ganesh Chindarkar serve as directors at the Company.
- CIN/LLPIN
U24239MH2007PTC173383
- Company No.
173383
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vivacious Pharmatex?
Board Members(3)
Financial Performance and Corporate Structure Insights of Vivacious Pharmatex.
Vivacious Pharmatex Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 389.84% increase. The company also saw a substantial improvement in profitability, with a 104.91% increase in profit. The company's net worth Soared by an impressive increase of 23.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivacious Pharmatex?
In 2022, Vivacious Pharmatex had a public holding of 32.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pan Oleo Chem24 Private Limited
Active
2 years 11 months Priya Shrivastav and Rupam Shrivastav are mutual person
Pan Oleo Enterprise Private Limited
Active 15 years 8 months Priya Shrivastav and Rupam Shrivastav are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 18 Mar 2023 | ₹4.00 M | Open |
Others Creation Date: 31 Mar 2021 | ₹4.00 M | Open |
Others Creation Date: 31 Mar 2017 | ₹3.00 Cr | Open |
How Many Employees Work at Vivacious Pharmatex?
Unlock and access historical data on people associated with Vivacious Pharmatex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 30, 2017, Vivacious Pharmatex has raised a total of ₹ 2.3 Cr, with the most recent deal valued at ₹ 1 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
